Mmbg Investment Advisors CO. Grows Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Mmbg Investment Advisors CO. raised its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 13.6% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,216 shares of the healthcare conglomerate's stock after acquiring an additional 1,225 shares during the period. Mmbg Investment Advisors CO.'s holdings in UnitedHealth Group were worth $5,351,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Norges Bank bought a new position in shares of UnitedHealth Group in the 4th quarter valued at $6,375,744,000. GAMMA Investing LLC increased its stake in shares of UnitedHealth Group by 56,142.1% in the 1st quarter. GAMMA Investing LLC now owns 8,295,153 shares of the healthcare conglomerate's stock valued at $4,344,586,000 after purchasing an additional 8,280,404 shares during the last quarter. Raymond James Financial Inc. bought a new position in shares of UnitedHealth Group in the 4th quarter valued at $1,914,740,000. Amundi increased its stake in shares of UnitedHealth Group by 97.2% in the 4th quarter. Amundi now owns 6,069,100 shares of the healthcare conglomerate's stock valued at $3,183,132,000 after purchasing an additional 2,991,470 shares during the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in shares of UnitedHealth Group by 36.6% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 8,592,718 shares of the healthcare conglomerate's stock valued at $4,346,712,000 after purchasing an additional 2,301,010 shares during the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other UnitedHealth Group news, Director John H. Noseworthy acquired 300 shares of the stock in a transaction that occurred on Wednesday, May 14th. The shares were bought at an average price of $312.16 per share, for a total transaction of $93,648.00. Following the completion of the transaction, the director now owns 6,063 shares of the company's stock, valued at approximately $1,892,626.08. This represents a 5.21% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Timothy Patrick Flynn acquired 1,533 shares of the stock in a transaction that occurred on Wednesday, May 14th. The stock was acquired at an average price of $320.80 per share, for a total transaction of $491,786.40. Following the transaction, the director now directly owns 6,033 shares of the company's stock, valued at $1,935,386.40. This represents a 34.07% increase in their position. The disclosure for this purchase can be found here. Over the last quarter, insiders have acquired 109,408 shares of company stock worth $31,607,768. Corporate insiders own 0.28% of the company's stock.

UnitedHealth Group Stock Performance

NYSE UNH traded up $6.23 on Friday, hitting $308.85. 13,584,804 shares of the stock traded hands, compared to its average volume of 7,404,577. The business's fifty day moving average is $336.21 and its two-hundred day moving average is $453.97. UnitedHealth Group Incorporated has a 12 month low of $248.88 and a 12 month high of $630.73. The firm has a market capitalization of $280.17 billion, a price-to-earnings ratio of 12.93, a PEG ratio of 1.46 and a beta of 0.44. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.85 and a current ratio of 0.85.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. The firm had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. During the same period last year, the company posted $6.91 earnings per share. As a group, equities analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th were issued a $2.21 dividend. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.86%. The ex-dividend date was Monday, June 16th. UnitedHealth Group's dividend payout ratio (DPR) is presently 37.02%.

Analyst Ratings Changes

Several equities analysts have recently issued reports on UNH shares. Baird R W lowered UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, June 11th. TD Cowen lowered UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 price objective on the stock. in a research report on Monday, May 19th. Oppenheimer cut their target price on UnitedHealth Group from $600.00 to $400.00 and set an "outperform" rating on the stock in a report on Wednesday, May 14th. Raymond James Financial downgraded UnitedHealth Group from a "strong-buy" rating to a "market perform" rating in a report on Wednesday, May 14th. Finally, Royal Bank Of Canada cut their target price on UnitedHealth Group from $525.00 to $355.00 and set an "outperform" rating on the stock in a report on Friday, May 16th. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and sixteen have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $415.57.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.